Tiziana Life Sciences (NASDAQ:TLSA) rises after the company said it is planning the submission of its Investigational New ...
Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.
"Receiving orphan drug designation from the FDA is a significant milestone for DiagnaMed and validates the promise of molecular hydrogen as a potential treatment for ALS. We are excited to partner ...
21h
StudyFinds on MSNBreakthrough blood test could transform ALS diagnosis, careFrench researchers have identified a blood test that could revolutionize how amyotrophic lateral sclerosis (ALS) is diagnosed ...
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. Neurology , 2025; 104 (6) DOI: 10.1212/WNL.0000000000213400 Cite This Page : ...
Tetramethylpyrazine nitrone is safe for ALS and may slow grip strength decline, especially in younger patients.
Legendary "If Ever I See You Again" singer Roberta Flack has passed away at the age of 88 at her home in Manhattan surrounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results